PL438501A1 - Composition in the form of a nanoemulsion based on vegetable oil, a multi-phase composition and method for preparing these compositions - Google Patents

Composition in the form of a nanoemulsion based on vegetable oil, a multi-phase composition and method for preparing these compositions

Info

Publication number
PL438501A1
PL438501A1 PL438501A PL43850121A PL438501A1 PL 438501 A1 PL438501 A1 PL 438501A1 PL 438501 A PL438501 A PL 438501A PL 43850121 A PL43850121 A PL 43850121A PL 438501 A1 PL438501 A1 PL 438501A1
Authority
PL
Poland
Prior art keywords
mass
parts
composition
vegetable oil
phase
Prior art date
Application number
PL438501A
Other languages
Polish (pl)
Inventor
Katarzyna Małolepsza-Jarmołowska
Michał Smoleński
Original Assignee
Uniwersytet Medyczny Im.Piastów Śląskich We Wrocławiu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Medyczny Im.Piastów Śląskich We Wrocławiu filed Critical Uniwersytet Medyczny Im.Piastów Śląskich We Wrocławiu
Priority to PL438501A priority Critical patent/PL438501A1/en
Priority to PCT/PL2022/000039 priority patent/WO2023287309A1/en
Publication of PL438501A1 publication Critical patent/PL438501A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

Pierwszym przedmiotem wynalazku jest kompozycja w postaci nanoemulsji na bazie oleju roślinnego, charakteryzująca się tym, że zawiera olej roślinny, który stanowi olej rzepakowy, w ilości od 10 do 60 części masowych oleju rzepakowego, od 12 do 20 części masowych poloksameru 188, od 40 do 60 części masowych wody oczyszczonej, od 1 do 12 części masowych Spanu 80, od 5 do 20 części masowych poliolu, od 0,10 do 0,50 części masowych kwasu mlekowego, od 0,5 do 5,0 części masowych klotrimazolu, przy czym krople fazy olejowej mają średnicę hydrodynamiczną od 50 nm do 70 nm. Drugim przedmiotem wynalazku jest kompozycja wielofazowa na bazie nanoemulsji oleju roślinnego, charakteryzująca się tym, że zawiera fazę polisacharydową w ilości od 10 do 50 części masowych i nanoemulsję wg pierwszego przedmiotu wynalazku w ilości od 50 do 90 części masowych, przy czym kompozycja wielofazowa ma postać nanoemulżelu, przy czym kompozycja wielofazowa ma lepkość dynamiczną od 220 mPa•s do 580 mPa•s. Wynalazek obejmuje także sposoby otrzymywania rzeczonych kompozycji.The first object of the invention is a composition in the form of a nanoemulsion based on vegetable oil, characterized in that it contains vegetable oil, which is rapeseed oil, in an amount of 10 to 60 parts by mass of rapeseed oil, 12 to 20 parts by mass of poloxamer 188, 40 to 60 parts by mass of purified water, from 1 to 12 parts by mass of Span 80, from 5 to 20 parts by mass of polyol, from 0.10 to 0.50 parts by mass of lactic acid, from 0.5 to 5.0 parts by mass of clotrimazole, with the oil phase droplets have a hydrodynamic diameter of 50 nm to 70 nm. The second subject of the invention is a multi-phase composition based on vegetable oil nanoemulsion, characterized in that it contains a polysaccharide phase in an amount of 10 to 50 parts by mass and a nanoemulsion according to the first subject of the invention in an amount of 50 to 90 parts by mass, wherein the multi-phase composition is in the form of a nanoemulgel wherein the multiphase composition has a dynamic viscosity of from 220 mPa•s to 580 mPa•s. The invention also includes methods for preparing said compositions.

PL438501A 2021-07-16 2021-07-16 Composition in the form of a nanoemulsion based on vegetable oil, a multi-phase composition and method for preparing these compositions PL438501A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL438501A PL438501A1 (en) 2021-07-16 2021-07-16 Composition in the form of a nanoemulsion based on vegetable oil, a multi-phase composition and method for preparing these compositions
PCT/PL2022/000039 WO2023287309A1 (en) 2021-07-16 2022-07-15 Pharmaceutical composition in the form of vegetable oil-based nanoemulsion, multiphase composition and method of preparation of these compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL438501A PL438501A1 (en) 2021-07-16 2021-07-16 Composition in the form of a nanoemulsion based on vegetable oil, a multi-phase composition and method for preparing these compositions

Publications (1)

Publication Number Publication Date
PL438501A1 true PL438501A1 (en) 2023-01-23

Family

ID=83546936

Family Applications (1)

Application Number Title Priority Date Filing Date
PL438501A PL438501A1 (en) 2021-07-16 2021-07-16 Composition in the form of a nanoemulsion based on vegetable oil, a multi-phase composition and method for preparing these compositions

Country Status (2)

Country Link
PL (1) PL438501A1 (en)
WO (1) WO2023287309A1 (en)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2094688B1 (en) * 1994-08-08 1997-08-01 Cusi Lab MANOEMULSION OF THE TYPE OF OIL IN WATER, USEFUL AS AN OPHTHALMIC VEHICLE AND PROCEDURE FOR ITS PREPARATION.
KR20040028336A (en) * 2002-09-30 2004-04-03 김종국 Novel composite of thermosensitive antifungal gel for vaginal administration
CN1931163A (en) * 2006-09-20 2007-03-21 西北农林科技大学 Nanometer clotrimazole emulsion medicine and its prepn process
PL210178B1 (en) * 2007-06-15 2011-12-30 Politechnika Wroclawska Production method of emulsion stabilized with surfactants
CN101909654A (en) * 2007-11-28 2010-12-08 联邦科学和工业研究组织 Nanoemulsions
DE102008034944B4 (en) * 2008-07-26 2017-03-16 Arivine Pharma Ag microemulsion
DE202014010412U1 (en) * 2014-02-21 2015-09-01 Ursapharm Arzneimittel Gmbh Micro or nanoemulsion for ophthalmic application
CN110664733A (en) * 2019-10-09 2020-01-10 华欧研创生物科技(深圳)有限公司 Hyaluronic acid nanoemulsion gel for nursing female vagina

Also Published As

Publication number Publication date
WO2023287309A1 (en) 2023-01-19

Similar Documents

Publication Publication Date Title
MX2017010814A (en) Stable dispersions.
BRPI0515091A (en) catalyst composition suitable for heavy oil hydroconversion
MX349440B (en) Wellbore servicing compositions and methods of making and using same.
BR112012005155A2 (en) lubricant composition and uses of a lubricant composition and an ionic liquid
SG179416A1 (en) Lubricant base oil, method for production thereof, and lubricant oil composition
BR112012006950A2 (en) viscosity modifier for lubricating oils, additive composition for lubricating oils, and lubricating oil composition
WO2012128834A3 (en) Process for making high viscosity index lubricating base oils
TW200616667A (en) Hair care composition
MX2010003302A (en) Tractor hydraulic fluid compositions and preparation thereof.
BRPI0909630B8 (en) aqueous suspension composition particularly suitable for injection into the eye
WO2009000068A8 (en) Drilling fluid additive and method for improving lubricity or increasing rate of penetration in a drilling operation
MX2015009619A (en) Natural oil based grease compositions and processes for making such compositions.
RU2018122295A (en) BEVERAGE NANO EMULSIONS OBTAINED WITH HIGH-SHIFT PROCESSING
MX2022006082A (en) Binder composition including bio-based component.
PL438501A1 (en) Composition in the form of a nanoemulsion based on vegetable oil, a multi-phase composition and method for preparing these compositions
WO2014128060A3 (en) Oil-in-water emulsion comprising at least one specific mixture of nonionic surfactants, a wax comprising at least one ester and a water-soluble polysaccharide
WO2014097258A3 (en) Aqueous cosmetic composition comprising alkylcellulose
WO2013040331A3 (en) Method for preparing personal care composition comprising surfactant system and high melting point fatty compound
BR112018013014A2 (en) personal care compositions
WO2011000801A3 (en) Personal care emulsions comprising waxy materials and organopolysiloxanes
SG146562A1 (en) Lubricant compositions with improved properties
CN106084128A (en) Lubricating oil anti-coagulants and preparation method and application
BR112013020279A2 (en) "oil in water emulsion or water in oil based vegetable oils as a plant protection adjuvant"
WO2019123261A3 (en) Oral compositions and methods of use
NZ596429A (en) Oil-in-water emulsion of mometasone and propylene glycol